Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ISRG NYSEARCA:XLV On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeISRGIntuitive Surgical$448.43+3.2%$455.44$425.00▼$616.00$161.01B1.612.06 million shs1.36 million shsXLVHealth Care Select Sector SPDR Fund$143.34+0.7%$138.07$127.35▼$153.49$35.90B0.711.54 million shs6.63 million shs10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceISRGIntuitive Surgical-0.23%-2.06%+0.03%-16.20%-8.81%XLVHealth Care Select Sector SPDR Fund-0.17%-1.30%+3.94%+7.95%-7.15%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeISRGIntuitive Surgical$448.43+3.2%$455.44$425.00▼$616.00$161.01B1.612.06 million shs1.36 million shsXLVHealth Care Select Sector SPDR Fund$143.34+0.7%$138.07$127.35▼$153.49$35.90B0.711.54 million shs6.63 million shs10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceISRGIntuitive Surgical-0.23%-2.06%+0.03%-16.20%-8.81%XLVHealth Care Select Sector SPDR Fund-0.17%-1.30%+3.94%+7.95%-7.15%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceISRGIntuitive Surgical 2.57Moderate Buy$580.2929.40% UpsideXLVHealth Care Select Sector SPDR Fund 2.66Moderate Buy$142.47-0.60% DownsideCurrent Analyst Ratings BreakdownLatest XLV and ISRG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/15/2025ISRGIntuitive SurgicalRobert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$600.00 ➝ $536.0010/15/2025ISRGIntuitive SurgicalTruist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$600.00 ➝ $525.0010/14/2025ISRGIntuitive SurgicalMizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$570.00 ➝ $520.0010/13/2025ISRGIntuitive SurgicalUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$529.0010/13/2025ISRGIntuitive SurgicalBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$571.00 ➝ $529.0010/8/2025ISRGIntuitive SurgicalWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C+)10/7/2025ISRGIntuitive SurgicalEvercore ISISubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetIn-Line$535.00 ➝ $450.0010/1/2025ISRGIntuitive SurgicalThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$621.00 ➝ $567.0010/1/2025ISRGIntuitive SurgicalBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$571.009/27/2025ISRGIntuitive SurgicalWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C+)(Data available from 10/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookISRGIntuitive Surgical$8.35B19.25$8.22 per share54.53$46.41 per share9.66XLVHealth Care Select Sector SPDR FundN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateISRGIntuitive Surgical$2.32B$7.1762.6458.774.5728.51%14.56%12.93%10/21/2025 (Estimated)XLVHealth Care Select Sector SPDR FundN/AN/A21.15∞N/AN/AN/AN/AN/ALatest XLV and ISRG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails10/21/2025Q3 2025ISRGIntuitive Surgical$2.00N/AN/AN/A$2.41 billionN/A7/22/2025Q2 2025ISRGIntuitive Surgical$1.93$2.19+$0.26$1.81$2.35 billion$2.44 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthISRGIntuitive SurgicalN/AN/AN/AN/AN/AXLVHealth Care Select Sector SPDR Fund$2.441.70%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioISRGIntuitive SurgicalN/A5.174.18XLVHealth Care Select Sector SPDR FundN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipISRGIntuitive Surgical83.64%XLVHealth Care Select Sector SPDR FundN/AInsider OwnershipCompanyInsider OwnershipISRGIntuitive Surgical0.70%XLVHealth Care Select Sector SPDR FundN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableISRGIntuitive Surgical15,638358.48 million355.97 millionOptionableXLVHealth Care Select Sector SPDR FundN/A250.57 millionN/ANot OptionableXLV and ISRG HeadlinesRecent News About These CompaniesNew Prescription for Gains: Behind Q4 Healthcare LeadOctober 15 at 7:56 AM | etftrends.comEShould You Invest in the Health Care Select Sector SPDR ETF (XLV)?October 14 at 7:21 AM | zacks.comWhy Congress Is Buying Intuitive Surgical Ahead of Earnings (XLV)...October 14 at 7:08 AM | marketbeat.comIf the AI Bubble Bursts, Here Are Some Defensive ETFs to ConsiderOctober 9, 2025 | zacks.com5 Healthcare Plays Powering the Sector’s Big Comeback (XLV)...October 9, 2025 | marketbeat.comUnitedHealth's Quarterly Earnings Preview: What You Need to KnowOctober 8, 2025 | finance.yahoo.comUS Government Shutdown Puts These ETFs in FocusOctober 2, 2025 | zacks.comHealth Care Stocks Rally, Nike Beats The Street: What's Moving Markets Wednesday?October 1, 2025 | msn.comIs Intuitive Surgical the Hidden Winner in Healthcare's Weakness?October 1, 2025 | msn.comIs Intuitive Surgical the Hidden Winner in Healthcare’s Weakness? (XLV)...October 1, 2025 | marketbeat.comRevvity Stock: Is RVTY Underperforming the Healthcare Sector?September 23, 2025 | msn.comBoost Your Portfolio With These Top-Ranked ETFsSeptember 19, 2025 | zacks.comSenator Jack Reed has filed a new financial disclosure - here’s what we seeSeptember 18, 2025 | quiverquant.comQHow Is ResMed's Stock Performance Compared to Other Healthcare Stocks?September 15, 2025 | msn.comXLV: Market Overreaction Could Drive Double Digit Shareholder YieldSeptember 12, 2025 | seekingalpha.comDownbeat August Jobs Data Puts Focus on These Sector ETFsSeptember 8, 2025 | zacks.comHealthcare Valuations Near Multi-Year Lows Suggest Risk–Reward AsymmetrySeptember 2, 2025 | investing.comIs Healthcare Setting Up to Be a Quiet Leader Into Year-End?...September 2, 2025 | marketbeat.comXLV Vs. IHE: Will Pharmaceuticals Outperform Healthcare?August 28, 2025 | seekingalpha.comHealthcare stocks: are they well-positioned to weather Trump tariffs?August 25, 2025 | invezz.comITop 5 ETFs and Stocks to Watch as the Fed Eyes Rate Cuts (XLV)...August 25, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSoundHound Breaks Critical Resistance: How High Can It Get Now?By Thomas Hughes | September 28, 2025The Fed Cut Rates: What Now for the S&P 500 and Equity Markets?By Thomas Hughes | September 18, 2025ISRG, TEAM, SFM Trade Well Below Highs With 30%+ UpsideBy Leo Miller | September 23, 2025Why Congress Is Buying Intuitive Surgical Ahead of EarningsBy Gabriel Osorio-Mazilli | October 14, 2025Is Intuitive Surgical the Hidden Winner in Healthcare’s Weakness?By Gabriel Osorio-Mazilli | October 1, 2025XLV and ISRG Company DescriptionsIntuitive Surgical NASDAQ:ISRG$448.26 +13.64 (+3.14%) As of 03:24 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.Health Care Select Sector SPDR Fund NYSEARCA:XLV$143.29 +0.97 (+0.68%) As of 03:24 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Health Care Select Sector SPDR Fund (the Fund) seeks to closely match the returns and characteristics of the S&P Health Care Select Sector Index (the Index). The companies included in the Index are selected on the basis of general industry classification from a universe of companies defined by the Standard & Poor's 500 Composite Stock Index (S&P 500). The Health Care Select Sector Index includes companies from the industries, such as pharmaceuticals, healthcare providers and services, healthcare equipment and supplies, biotechnology, life sciences tools and services, and healthcare technology. Under normal market conditions, the Fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the Index. State Street Global Advisors acts as the Fund's investment manager. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Archer Buys Rival's Patent Treasure Trove in Strategic Move Intel's Turnaround Hits Hyperspeed With A New 52-Week High Qualcomm: What Last Friday’s Drop Says About Its Q4 Prospects An AI Play Hiding in Plain Sight: A Look at Johnson Controls Energy Crunch Ahead: 3 Natural Gas Stocks Set to Gain Walmart's AI Play: OpenAI Deal Forges a New Path to Profitability AppLovin Drops 14%: Should Investors Worry About SEC Probe? Advanced Micro Devices Eyes $300 as AI Demand Surges Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
